Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Quality Improvement Article
  • Published:

Continuous infusion of vancomycin improved therapeutic levels in term and preterm infants

Abstract

Background

Growing evidence suggests that continuous infusion of vancomycin (CIV) is superior to intermittent infusion of vancomycin (IIV) in neonates. This quality improvement (QI) project aimed to transition from IIV to CIV with earlier and improved attainment of therapeutic vancomycin levels.

Methods

The Model for Improvement framework with Plan Do Study Act cycles was used. Prospective data were collected during three phases: IIV, CIV-1 and CIV-2.

Interventions

A QI team developed a CIV drug monograph and a multidisciplinary education package.

Results

Using IIV, 36% (9/25) of first vancomycin levels were within target range. CIV achieved therapeutic levels twice as quickly as IIV (p < 0.05) with improved first vancomycin target levels (IIV 36%, 9/25; CIV-1 55%, 16/29; CIV-2 61%, 14/23) and total therapeutic levels (IIV 44%, 37/84; CIV-1 56%, 55/98; CIV-2 69%, 79/114).

Conclusions

This QI project demonstrated a successful transition from IIV to CIV with reduced time to achieve target vancomycin and an increased proportion of therapeutic levels.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Summary of continuous infusion of vancomycin monograph and therapeutic drug monitoring schedule.
Fig. 2: Plan Do Study Act (PDSA) diagram summarising the actions involved in each stage of the project.

Similar content being viewed by others

References

  1. Cailes B, Kortsalioudaki C, Buttery J, Pattnayak S, Greenough A, Matthes J, et al. Epidemiology of UK neonatal infections: the neonIN infection surveillance network. Arch Dis Child Fetal Neonatal Ed. 2018;103:F547-F553.

    Article  Google Scholar 

  2. NICE. Neonatal infection (early onset): antibiotics for prevention and treatment. 2012. https://www.nice.org.uk/guidance/CG149.

  3. Dong Y, Speer CP. Late-onset neonatal sepsis: recent developments. Arch Dis Child Fetal Neonatal Ed. 2015;100:F257-63.

    Article  Google Scholar 

  4. De Hoog M, Mouton JW, Van Den Anker JN. Vancomycin: Pharmacokinetics and administration regimens in neonates. Clin Pharmacokinet. 2004;43:417–40.

    Article  CAS  Google Scholar 

  5. Moise-Broder PA, Forrest A, Birmingham MC, Schentag JJ. Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections. Clin Pharmacokinet. 2004;43:925–42.

    Article  CAS  Google Scholar 

  6. British National Formulary for Children. Vancomycin. 2020. https://bnfc.nice.org.uk/drug/vancomycin.html.

  7. Wysocki M, Delatour F, Faurisson F, Rauss A, Pean Y, Misset B, et al. Continuous versus intermittent infusion of vancomycin in severe staphylococcal infections: Prospective multicenter randomized study. Antimicrob Agents Chemother. 2001;45:2460–7.

    Article  CAS  Google Scholar 

  8. Cataldo MA, Tacconelli E, Grilli E, Pea F, Petrosillo N. Continuous versus intermittent infusion of vancomycin for the treatment of gram-positive infections: systematic review and meta-analysis. J Antimicrob Chemother. 2012;67:17–24.

    Article  CAS  Google Scholar 

  9. Patel AD, Anand D, Lucas C, Thomson AH. Continuous infusion of vancomycin in neonates. Arch Dis Child. 2013;98:478–9.

    Article  Google Scholar 

  10. Gwee A, Cranswick N, McMullan B, Perkins E, Bolisetty S, Gardiner K, et al. Continuous versus intermittent vancomycin infusions in infants: a randomized controlled trial. Pediatrics. 2019;143:e20182179.

    Article  Google Scholar 

  11. Kim J, Walker SAN, Iaboni DC, Walker SE, Elligsen M, Dunn MS, et al. Determination of vancomycin pharmacokinetics in neonates to develop practical initial dosing recommendations. Antimicrob Agents Chemother. 2014;58:2830–40.

    Article  Google Scholar 

  12. Gwee A, Cranswick N, Metz D, Coghlan B, Daley AJ, Bryant PA, et al. Neonatal vancomycin continuous infusion: still a confusion? Pediatr Infect Dis J. 2014;33:600–5.

    Article  Google Scholar 

  13. Ward RM, Allegaert K, De Groot R, Van Den Anker JN. Commentary: continuous infusion of vancomycin in neonates: to use or not to use remains the question. Pediatr Infect Dis J. 2014;33:606–7.

    Article  Google Scholar 

  14. Zhao W, Lopez E, Biran V, Durrmeyer X, Fakhoury M, Jacqz-Aigrain E. Vancomycin continuous infusion in neonates: dosing optimisation and therapeutic drug monitoring. Arch Dis Child. 2013;98:449–53.

    Article  Google Scholar 

  15. Mahieu LM, De Dooy JJ, Lenaerts AE, Ieven MM, De Muynck AO. Catheter manipulations and the risk of catheter-associated bloodstream infection in Neonatal Intensive Care Unit patients. J Hosp Infect. 2001;48:20–6.

    Article  CAS  Google Scholar 

  16. Pacifici GM, Allegaert K. Clinical pharmacokinetics of vancomycin in the neonate: a review. Clinics. 2012;67:831–7.

    Article  Google Scholar 

  17. Rybak M, Lomaestro B, Rotschafer JC, Moellering R, Craig W, Billeter M, et al. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm. 2009;66:82–98.

    Article  CAS  Google Scholar 

  18. Rasigade JP, Raulin O, Picaud JC, Tellini C, Bes M, Grando J, et al. Methicillin-resistant Staphylococcus capitis with reduced vancomycin susceptibility causes late-onset sepsis in intensive care neonates. PLoS ONE. 2012;7:e31548.

    Article  CAS  Google Scholar 

  19. Butin M, Martins-Simões P, Picaud JC, Kearns A, Claris O, Vandenesch F, et al. Adaptation to vancomycin pressure of multiresistant Staphylococcus capitis NRCS—a involved in neonatal sepsis. J Antimicrob Chemother. 2015;70:3027–31.

    Article  CAS  Google Scholar 

  20. Butin M, Martins-Simões P, Rasigade JP, Picaud JC, Laurent F. Worldwide endemicity of a multidrug-resistant Staphylococcus capitis clone involved in neonatal sepsis. Emerg Infect Dis. 2017;23:538–9.

    Article  Google Scholar 

  21. Frymoyer A, Hersh AL, El-Komy MH, Gaskari S, Su F, Drover DR, et al. Association between vancomycin trough concentration and area under the concentration-time curve in neonates. Antimicrob Agents Chemother. 2014;58:6454–61.

    Article  Google Scholar 

  22. University Hospitals of Leicester NHS Trust. The Leicester neonatal service. https://www.leicestershospitals.nhs.uk/aboutus/departments-services/neonatal-service/ (2020).

Download references

Acknowledgements

We would like to thank the Clinical Audit Department of University Hospitals of Leicester NHS Trust in their support of this work.

Author information

Authors and Affiliations

Authors

Contributions

KFN and SM contributed to the conception of the project. All listed authors contributed to the acquisition of data. AR initially drafted the paper, with KFN subsequently editing. All authors were then involved in revising and final approval of the paper. All authors agree to be accountable for all aspects of the work and its integrity.

Corresponding author

Correspondence to Antonia Round.

Ethics declarations

Conflict of interest

The authors declare that they have no conflicts of interest.

Ethical approval

This quality improvement project was approved by the UHL Clinical Audit Department. Audit registration number was 10080.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Round, A., Clifton, E., Stachow, L. et al. Continuous infusion of vancomycin improved therapeutic levels in term and preterm infants. J Perinatol 41, 1459–1466 (2021). https://doi.org/10.1038/s41372-020-00909-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41372-020-00909-3

This article is cited by

Search

Quick links